Astrazeneca (AZN) Cash from Operations (2009 - 2019)

Astrazeneca (AZN) has reported Cash from Operations for 9 consecutive years, with 1040000000.0 the latest figure, recorded in Q2 2020.

• In Q2 2020, Cash from Operations changed N/A year-over-year to 1040000000.0; the TTM figure through Jun 2020 stood at 1463931561.09 (changed N/A YoY), while the FY2025 annual figure was 18736000000.0, up 17.66% from the prior year.
• Cash from Operations came in at 1040000000.0 for Q2 2020 at Astrazeneca, up from 387000000.0 in the prior quarter.
• The five-year high for Cash from Operations was 1040000000.0 in Q2 2020, with the low at 387000000.0 in Q1 2019.
• Average Cash from Operations over 3 years is 507386649.65, with a median of 869159948.96 recorded in 2016.
• The largest YoY upside for Cash from Operations was 1592.67% in 2016 against a maximum downside of 1592.67% in 2016.
• Year by year, Cash from Operations stood at 869159948.96 in 2016, then sank by 144.53% to 387000000.0 in 2019, then jumped by 368.73% to 1040000000.0 in 2020.
• According to Business Quant data, Cash from Operations over the past three periods registered 1040000000.0, 387000000.0, and 869159948.96 for Q2 2020, Q1 2019, and Q1 2016 respectively.